Boardroom Alpha
Boardroom Alpha
SPNT · Current Report (Form 8-K) · Filed March 16, 2026

Siriuspoint Ltd — Current Report (Form 8-K)

Form
8-K
Filed
March 16, 2026
Period
Mar 16, 2026
Ticker
SPNT
Accession
0001576018-26-000036
Boardroom Alpha · Filing insights

SiriusPoint restructures into four units; Rob Gibbs, CEO of SiriusPoint International, will depart with a separation plan.

About Siriuspoint Ltd
Market cap
$2.8B
1Y TSR
+27.0%
3Y TSR
+30.7%
Board grade
B+
Sector
Financial Services
CEO
Scott Egan
Last annual meeting: May 20, 2026 · View full Siriuspoint Ltd profile →
tpre-20260316

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): March 16, 2026 (March 16, 2026)
 
 SIRIUSPOINT LTD.
(Exact name of registrant as specified in its charter)
  
Bermuda 001-36052 98-1599372
(State or other jurisdiction
of incorporation)
 (Commission
File Number)
 (I.R.S. Employer
Identification No.)
Point Building
3 Waterloo Lane
Pembroke HM 08 Bermuda
(Address of principal executive offices and Zip Code)
Registrant’s telephone number, including area code: +1 441 542-3300
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Common Shares, $0.10 par valueSPNTNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On March 16, 2026, SiriusPoint Ltd. (“Company”) announced changes to its business structure under which it will now operate through four business areas, including three globally focused areas: Global Property & Casualty Programs, Global Reinsurance, Global Accident & Health, and a London Market Specialty division, which includes Lloyd’s. As part of these business structure changes, Mr. Rob Gibbs, President & Chief Executive Officer of SiriusPoint International, will be leaving the Company.

The Company and Mr. Gibbs are in the process of finalizing the separation date and a mutual separation agreement that will implement an orderly transition of his responsibilities, as well as confirm the severance benefits and post-termination obligations pursuant to the Company’s Executive Severance Plan, which was previously filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on August 5, 2025. Once the separation date is determined, the Company will disclose such date in a Current Report on Form 8-K
Item 7.01Regulation FD Disclosure

On March 16, 2026, the Company issued a press release, attached hereto as Exhibit 99.1, announcing changes to its business structure and the departure of Mr. Rob Gibbs, President & Chief Executive Officer of SiriusPoint International.

The information contained in this Item 7.01, including Exhibit 99.1, are being furnished pursuant to this Item 7.01. This information shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section, or incorporated by reference into any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.  Description
99.1
104Cover Page Interactive Data File (embedded within the Inline XBRL document).




SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: March 16, 2026
 
/s/ Linda S. Lin
 Name:Linda S. Lin
 Title:Chief Legal Officer & Corporate Secretary




From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Siriuspoint Ltd (SPNT)

Reference

Frequently asked questions

When did Siriuspoint Ltd file this 8-K?
Siriuspoint Ltd (SPNT) filed this Current Report (Form 8-K) with the SEC on March 16, 2026. The accession number assigned by EDGAR is 0001576018-26-000036.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
SiriusPoint restructures into four units; Rob Gibbs, CEO of SiriusPoint International, will depart with a separation plan. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Siriuspoint Ltd's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Siriuspoint Ltd has filed under CIK 1576018, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer